Amlodipine enhances the activity of antiepileptic drugs against pentylenetetrazole-induced seizures

Pharmacology Biochemistry and Behavior

Volumn 68, Issue 4, 2001, Pages 661-668

  Kamiński, Rafal M ^a   Mazurek, Marcin ^b   Turski, Waldemar A ^a,b   Kleinrok, Zdzislaw ^b   Czuczwar, Stanislaw J ^a,b  

^a INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Amlodipine; Antiepileptic drugs; Calcium antagonists; Pentylenetetrazole; Seizures

Indexed keywords

AMLODIPINE; ANTICONVULSIVE AGENT; ETHOSUXIMIDE; PENTETRAZOLE; PHENOBARBITAL; VALPROATE MAGNESIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHIMNEY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG POTENTIATION; MALE; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SEIZURE;

AMLODIPINE; ANIMALS; ANTICONVULSANTS; AVOIDANCE LEARNING; CALCIUM CHANNEL BLOCKERS; CONVULSANTS; DRUG SYNERGISM; MALE; MICE; PENTYLENETETRAZOLE; PSYCHOMOTOR PERFORMANCE; SEIZURES;

EID: 0035011185     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(01)00468-3     Document Type: Article

References (68)

1. Calcium-dependent regulation of genetically determined spike and waves by the reticular thalamic nucleus of rats
2. 2+ currents in acutely isolated human hippocampal granule cells
3. Open dose-ranging trial of flunarizine as add-on therapy in epilepsy
4. Une nouvelle méthode simple pour explorer l'action "tranquilisante": Le test de la chiminée
5. The behavioral effects of the calcium agonist Bay K 8644 in the mouse: Antagonism by the calcium antagonist nifedipine
6. Influence of isradipine, niguldipine and dantrolene on the anticonvulsive action of conventional antiepileptics in mice
7. Unique pharmacologic properties of amlodipine
8. Amlodipine: A novel calcium antagonist
9. Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons
10. Differential effects of petit mal anticonvulsants and convulsants on thalamic neurones: Calcium current reduction
11. 2+ uptake and amino acid neurotransmitter release in vitro
12. Effects of calcium channel inhibitors upon the efficacy of common antiepileptic drugs
13. Influence of calcium channel inhibitors upon the anticonvulsant efficacy of common antiepileptics against pentylenetetrazol-induced convulsions in mice
14. Influence of flunarizine, nicardipine and nimodipine on the anticonvulsant activity of different antiepileptic drugs in mice
15. Interaction of calcium channel blockers and excitatory amino acid antagonists with conventional antiepileptic drugs
16. Anticonvulsant effects of some calcium entry blockers in DBA/2 mice
17. Efficacy and safety of calcium channel blockers in heart failure: Focus on recent trials with second-generation dihydropyridines
18. Nimodipine facilitates associative learning in aging rabbits
19. Pharmacokinetic modeling of the anticonvulsant response of oxazepam in rats using the pentylenetetrazol threshold concentration as pharmacodynamic measure
20. 2+ channel blockers on apomorphine, bromocriptine and morphine-induced locomotor activity in mice
21. Animal models of the epilepsies
22. Comparative pharmacology of calcium blockers based on studies of cardiac output distribution
23. 2+ channels by amlodipine
24. 2+ channel blockade and the antielectroshock activity of NMDA receptor antagonists, CGP 40116 and CGP 43487, in mice
25. Influence of nicardipine, nimodipine and flunarizine on the anticonvulsant efficacy of antiepileptics against pentylenetetrazol in mice
26. 2+ channel inhibitors in mice
27. Nifedipine and flunarizine block amphetamine-induced behavioral stimulation in mice
28. Catalepsy induced by calcium channel blockers in mice
29. Application of calcium channel blockers in the treatment of cardiovascular diseases
30. Effect of amlodipine upon the protective activity of antiepileptic drugs against maximal electroshock-induced seizures in mice
31. Calcium channel blockers and excitatory amino acids
32. Different action of ethosuximide on low- and high-threshold calcium currents in rat sensory neurons
33. The limitations of antiepileptic drug monotherapy
34. Dihydropyridine calcium antagonists in mice: Blood and brain pharmacokinetics and efficacy against pentylenetetrazol seizures
35. Polypharmacy with anticonvulsants. Focus on synergism
36. A simplified method of evaluating dose-effect experiments
37. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on the experimental and clinical considerations
38. Use of animal models in developing guiding principles for polypharmacy in epilepsy
39. Inhibitory action of a calcium channel blocker (nimodipine) on seizures and brain damage induced by pilocarpine and lithium-pilocarpine in rats
40. Effects of established and new antiepileptic drugs
41. Inhibition of electrically induced seizures by a dihydropyridine calcium channel blocker
42. 2+ antagonist
43. Flunarizine as add-on therapy in epilepsy. Crossover study vs. placebo
44. The antiseizure activity of dihydropyridine calcium channel antagonists in the conscious rat
45. The effects of dihydropyridine calcium channel modulators on pentylenetetrazole convulsions
46. Pentylenetetrazole-induced seizure activity produces an increased release of calcium from endoplasmic reticulum by mediating cyclic AMP-dependent protein phosphorylation in rat cerebral cortex
47. Properties of the slow inward current induced by pentylenetetrazol in Helix neurons
48. Cognitive deficits in epilepsy and contribution to psychopathology
49. Psychopharmacological properties of calcium channel inhibitors
50. Effect of calcium channel blocker amlodipine on memory in mice
51. Some aspects of prognosis in the epilepsies: A review
52. Calcium currents in acutely isolated human neocortical neurons
53. Basic mechanism of epileptogenesis
54. Pharmacological models of generalized absence seizures in rodents
55. Voltage-activated calcium channels: Targets of antiepileptic drug therapy?
56. The metabolism and pharmacokinetics of amlodipine in human and animals
57. Different types of calcium channels mediate synaptic transmission
58. 2+ current in adult rat sensory neurons: Effects of anticonvulsant and anesthethic agents
59. The effect of nimodipine on picrotoxin-induced seizures
60. Selective increase in T-type calcium conductance of reticular thalamic neurons in a rat model of absence epilepsy
61. Brain pharmacokinetics and in vivo receptor binding of 1,4-dihydropyridine calcium channel antagonists
62. Benzodiazepines impair and beta-carbolines enhance performance in learning and memory tasks
63. Enhancement of calcium currents in rat hippocampal CA1 neurons induced by kindling epileptogenesis
64. Pathophysiological mechanisms of brain damage from status epilepticus
65. Calcium channel blockers verapamil and nimodipine inhibit kindling in adult and immature rats
66. Pharmacokinetics of amlodipine and its occupancy of calcium antagonist receptors
67. Relationship between pentylenetetrazol-induced seizures and brain pentylenetetrazol levels in mice
68. Effects of nimodipine, felodipine and amlodipine on electroconvulsive shock-induced amnesia in the rat